Medtronic MiniMed Paradigm Veo Insulin Pump: Arabic Translation Error in Predictive Alerts
Medtronic recalls MiniMed Paradigm Veo insulin pumps with catalog numbers MMT-554 and MMT-754 that have an Arabic language translation error in the Predictive Alerts setting screen. This error may cause incorrect alerts for low or high glucose levels.
Lower-risk recall
The MiniMed Paradigm Veo insulin pump has an error that impacts the Arabic language translation.This translation error occurs in the Predictive Alerts setting screen, which allows user to program alerts that will sound if users are predicted to reach their pre-set low or high sensor glucose values.
Contact the company
What happened, in plain English
Medtronic is recalling certain MiniMed Paradigm Veo insulin pumps (model numbers MMT-554 and MMT-754) because they have an Arabic language translation error in the Predictive Alerts setting. This error could lead to incorrect glucose level alerts, potentially causing users to miss important safety warnings. Read more at govinfonow.com/recall/71339-medtronic-minimed-paradigm-veo-insulin-pump-arabic-translation-error-in.
Source Summary by GovInfoNow · govinfonow.com/recall/71339-medtronic-minimed-paradigm-veo-insulin-pump-arabic-translation-error-in · Updated August 18, 2026 · FDA enforcement record: FDA #Z-2377-2018
Cite this page
“Medtronic MiniMed Paradigm Veo Insulin Pump: Arabic Translation Error in Predictive Alerts.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/71339-medtronic-minimed-paradigm-veo-insulin-pump-arabic-translation-error-in. Based on FDA recall #Z-2377-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2377-2018%22&limit=1).
Why it’s dangerous
The error occurs in the Predictive Alerts setting screen, which is used to program alerts for when users reach their pre-set low or high glucose levels. In Arabic, this feature may display incorrect messages, leading to potential misinterpretation of glucose levels and possibly missing critical safety alerts.
Who’s affected
Users of the MiniMed Paradigm Veo insulin pump with model numbers MMT-554 or MMT-754 who have the listed lot serial numbers are affected. People who use Arabic language settings on the pump are most at risk.
How to tell if you have this one
Check your pump's product catalog number (MMT-554 or MMT-754) and lot serial number against the list provided in the recall notice. The affected pumps have specific lot serial numbers starting with 'PAR' or 'PBR' followed by numbers and 'H' (e.g., PAR602720U, PBR300118H).
- Brand
Medtronic- Category
Medical device
What to do — step by step
Check Your Pump Model
Verify your pump's product catalog number (MMT-554 or MMT-754) and lot serial number against the list provided in the recall notice.
Contact Medtronic
If your pump is affected, contact Medtronic directly for instructions on how to update the language settings or replace the pump.
How this recall unfolded
Recall timeline
FDA terminated this recall 4 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Medtronic recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2377-2018 (April 24, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2377-2018 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.